Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

BEDMINSTER, New Jersey, and BORDEAUX, France, December 17 /PRNewswire/ --

Clinsys Clinical Research, Inc. and ITEC Services, both therapeutically focused clinical research organizations, today announced they have entered into a strategic alliance agreement that will broaden each company's global clinical research service offering. The alliance will enable Clinsys to extend its global clinical operations and consulting services in Europe and North Africa, while providing ITEC increased opportunities resulting from alignment with Clinsys' infrastructure and network of global resources in the United States, India and Western Europe.

HAMILTON, New Jersey, December 17 /PRNewswire/ --

EPV SOLAR, Inc. (formerly Energy Photovoltaics, Inc.), a thin-film solar module manufacturer and technology developer headquartered in New Jersey, USA, announced today that it has entered into a long-term solar module supply agreement with unlimited energy GmbH, Berlin, Germany. Under the terms of the contract, EPV SOLAR will supply 306 megawatts (MW) of amorphous silicon modules to unlimited energy for use in the development and build-out of several solar parks in Europe. EPV will begin shipments against this contract during the first quarter of 2008. Product will initially ship from EPV's New Jersey locations and shift to EPV's Senftenberg, Germany, plant scheduled to come online during the fourth quarter of 2008.

PRINCETON, New Jersey and UXBRIDGE, England, December 17 /PRNewswire/ --

- Product Developed Through Joint Venture Between Bristol-Myers Squibb and Gilead Sciences, the First of its Kind in HIV Treatment

The European Commission has granted marketing authorisation for ATRIPLA(R) 600 mg/200 mg/245 mg film-coated tablets. Each film-coated tablet contains 600 mg efavirenz, 200 mg emtricitabine and 245 mg tenofovir disoproxil (as fumarate). The decision means that ATRIPLA is formally approved for marketing in the 27 countries of the European Union, as well as in Norway and Iceland.

LONDON, December 17 /PRNewswire/ --

Endeavour International Corporation announced that its stock began trading today on the main market of the London Stock Exchange (LSE) under the ticker symbol ENDV.

"The listing on the LSE broadens our access to European markets which are more geographically focused on North Sea activities and the value our business strategy can add," said William L. Transier, chairman, chief executive officer and president. "With our growing management and operational presence in London and Oslo, it is fitting that we build closer ties with the local investment communities."

The company's shares will continue to trade on the American Stock Exchange under the symbol END.

MOSCOW, December 17 /PRNewswire/ --

Mechel OAO (NYSE: MTL), one of the leading Russian mining and metals companies, announces that the Company has acquired 49% of the shares of Toplofikatsia Rousse JSC (TPP "Rousse"), located in Rousse, Republic of Bulgaria. The acquisition is in line with Mechel's plans to develop the substantive power segment within the company's diversified business and enter new markets for its steam coal.

TORONTO, December 17 /PRNewswire/ --

- Free add-your-profile opportunity for colleges and universities on Facebook(R) Platform

Recent national surveys have found that 75% of college and university applicants are active Facebook users, and many discuss their plans for higher education using the social utility. SkoolPool(TM), a new application on Facebook Platform, offers a fast and effective way for institutions to share information with this key audience. With a SkoolPool membership, institutions get a profile page accessible through SkoolPool.com, SkoolPool on Facebook Platform, and on a Facebook Page designed and maintained by the Academica Group team.